J-Clinic announces new conference to explore the use of AI in drug discovery and development
The Abdul Latif Jameel Clinic for Machine Learning in Health (J-Clinic) at the Massachusetts Institute of Technology (MIT) has announced a new conference exploring the potential of using cutting-edge AI to revolutionize the discovery and development of drugs in future.
The MIT AIDM Conference is expected to draw an audience of academics, industry scientists, investors, regulators, government representatives, postdocs and students, taking part in lectures and panels with industry thought leaders to discuss the current state-of-the-art and bringing together research in machine learning and biotech.
The Conference will take place in February 2020; read more about it here.
J-Clinic was founded in 2018 as a collaboration between Community Jameel and MIT, with the aim to revolutionize disease prevention, detection, and treatment.
The core mission of J-Clinic is to incubate research at the intersection of computer science, big data, and the life sciences, and to drive the creation and commercialization of high-precision, affordable, and scalable machine-learning technologies to health care.
Read more about J-Clinic here.